EcoR1 Capital’s X4 Pharmaceuticals XFOR Stock Holding History

EcoR1 Capital’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,847	Closed	-$4.45M	–	60
2019 Q4	$4.45M	Buy	+13,847	New	+$4.97M	0.4%	36

Other funds holding XFOR

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EcoR1 Capital's XFOR Position: Q1 2020 in Review

EcoR1 Capital sold out of X4 Pharmaceuticals (XFOR) in Q1 2020, closing a stake of 13,847 shares — an estimated $4.45M sold.

EcoR1 Capital first reported a position in XFOR in Q4 2019 and held it in 1 quarter. The position peaked at $4.45M in Q4 2019. 50 funds tracked by Wall St. Rank hold XFOR as of Q1 2020.

EcoR1 Capital reported no remaining X4 Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
EcoR1 Capital sold 13,847 X4 Pharmaceuticals shares in Q1 2020, an estimated $4.45M.
EcoR1 Capital first reported a position in X4 Pharmaceuticals in Q4 2019 and held it in 1 quarter.
EcoR1 Capital's X4 Pharmaceuticals position peaked at $4.45M in Q4 2019.
50 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2020.

Based on EcoR1 Capital's 13F filing for Q1 2020, filed 15 May 2020.